Saxenburgh Medisch Centrum
- Address
- lock Available on a paid plan
Cardiovascular Diseases
At Saxenburgh Medisch Centrum, most of the clinical research focuses on cardiovascular disease, especially efforts to lower heart attack and stroke risk, improve care in atrial fibrillation, and support patients with heart failure and related complications.
- Testing new approaches to reduce major cardiovascular events in high-risk patients
- Studying treatments for stroke prevention in atrial fibrillation
- Evaluating therapies for heart failure, including cases with kidney impairment
- Assessing medicines aimed at lowering elevated lipoprotein(a) and related cardiovascular risk
These studies are designed to improve prevention, treatment effectiveness, and long-term outcomes in people with established or high-risk cardiovascular conditions.
Nutritional and Metabolic Diseases
The site also supports research in nutritional and metabolic diseases, with trials involving type 2 diabetes and conditions linked to metabolic risk that can affect the heart and kidneys.
- Evaluating a new treatment option for people with type 2 diabetes and high cardiovascular risk
- Studying therapies that may improve outcomes in patients with metabolic disease and cardiovascular complications
- Exploring ways to reduce the burden of diabetes-related cardiovascular events
These trials aim to strengthen disease control while also lowering the chance of serious heart-related events in people with complex metabolic illness.
Hormonal Diseases
Research in hormonal diseases at this hospital includes studies in hypothyroidism, with attention to patients who continue to experience symptoms despite standard treatment.
- Comparing treatment strategies for persistent tiredness in autoimmune hypothyroidism
- Investigating whether combination hormone therapy may better relieve ongoing symptoms
- Looking at whether certain genetic factors influence response to thyroid treatment
This work is aimed at improving symptom relief and helping clinicians better tailor treatment for people living with thyroid-related disorders.
Neoplasms
The oncology-related research at Saxenburgh Medisch Centrum includes studies in breast cancer and multiple myeloma, focusing on better treatment strategies and disease control.
- Testing treatment sequences for hormone receptor-positive breast cancer to improve disease control
- Assessing whether a treatment-free interval may be feasible in newly diagnosed multiple myeloma
- Exploring ways to improve progression-free survival and overall cancer management
These trials are intended to refine cancer care by finding approaches that may extend benefit while supporting patient quality of life.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 of 3 therapeutic areas and 15 of 21 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 7 by active trials.
- 1Novartis Pharma AG1active
lock +6 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novartis Pharma AG4trials
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Saxenburgh Medisch Centrum
lock Showing 1 of 15 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Balcinrenone and Dapagliflozin on Cardiovascular Outcomes in Heart Failure Patients with Renal Impairment: A Phase III Randomized, Double-Blind Study | AstraZeneca AB | Phase III | Recruiting | Jul 2024 | — |
IMP list
lock Showing 1 of 21 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dapagliflozin | 3 | Unknown | 2022-11-08 | 2024-07-12 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.